PPP3CA and acute lymphoblastic leukemia: By inhibiting pathways enriched in our PPP3CA protein complex we identified the dual PI3K-mTOR inhibitor BEZ235 as a promising drug in synergizing with Cn inhibitors to promote T-ALL cell death.